BEVERLY, Mass. and TORONTO, July 27, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that David Wolf, President and CEO of Hamilton Thorne Ltd., will deliver a presentation at the upcoming Canaccord Genuity 42nd Annual Growth Conference to be held at the InterContinental Boston Hotel, Boston, Massachusetts on Wednesday, August 10, 2022 at 10:00 am EDT, and will be available for one-on-one meetings during the conference. To schedule a meeting with management, please contact your conference representative or email [email protected].
About Hamilton Thorne Ltd. (www.hamiltonthorne.ltd)
Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.
Neither the TSX Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.
For more information, please contact:
|David Wolf, President & CEO||Michael Bruns, CFO||Glen Akselrod|
|Hamilton Thorne Ltd.||Hamilton Thorne Ltd.||Bristol Investor Relations|
|[email protected]||[email protected]||[email protected]|